If a clinical researcher with a focus on diagnosing and detecting rare cancers found out they have a rare form of blood cancer, what stops them from using their own samples for research? Would this be a conflict of interest severe enough that they would have to back out of their research?
In: 1
The gold standard in medical studies are what are known as double blind studies, which means that the researchers themselves don’t know anything about the samples they are processing. Such safeguards are necessary to maintain the integrity of the data generated by the study and ensure that no bias, conscious or unconscious, alters the outcome of the study.
Latest Answers